New York State Common Retirement Fund Recursion Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 63,375 shares of RXRX stock, worth $436,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,375
Previous 84,875
25.33%
Holding current value
$436,020
Previous $637,000
34.38%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$225 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$174 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$167 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$119 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$106 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.24B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...